💊 Ipsen buys Epizyme; Cipla invests in GoApptiv; Sanofi partners with Health2Sync
GCC losing billions by not treating mental health
Hello and welcome back to an unusually-light-for-a-Tuesday Kable. Not much happening around the life sciences world today, it would seem. Thankfully, a consulting firm released a report, so there are many astonishing insights to pore over.
Apart from that Deloitte revelation, in today’s Kable: India launches a One Health pilot; Japan wants to fix your b…
Keep reading with a 7-day free trial
Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.